Pery N, Payen D, Pinsky M R
Department of Anesthesiology and Intensive Care Medicine, Lariboisière University Hospital, Paris, France.
Chest. 1991 Feb;99(2):512-3. doi: 10.1378/chest.99.2.512.
The hypothetic benefit of CPAP on cardiac performance and on a reduction in VO2 was tested in a patient before heart transplantation after acute myocardial infarction using continuous SvO2 monitoring. The CPAP added to inotropic support (enoximone plus dobutamine) and intraaortic balloon pumping dramatically increased SvO2 in relation to both an increase in cardiac output and a decrease in VO2 secondary to respiratory work reduction, validating the initial hypotheses.
在一名急性心肌梗死后心脏移植前的患者中,通过持续监测混合静脉血氧饱和度(SvO2),对持续气道正压通气(CPAP)对心脏功能及降低耗氧量(VO2)的假设益处进行了测试。在使用血管活性药物支持(依诺昔酮加多巴酚丁胺)和主动脉内球囊反搏的基础上加用CPAP,显著提高了SvO2,这与心输出量增加以及因呼吸功减少导致的VO2降低有关,证实了最初的假设。